Literature DB >> 32783106

Metagenomic next-generation sequencing of rectal swabs for the surveillance of antimicrobial-resistant organisms on the Illumina Miseq and Oxford MinION platforms.

Rebecca Yee1, Florian P Breitwieser2, Stephanie Hao3, Belita N A Opene1, Rachael E Workman3, Pranita D Tamma4, Jennifer Dien-Bard5, Winston Timp3, Patricia J Simner6.   

Abstract

Antimicrobial resistance (AMR) is a public health threat where efficient surveillance is needed to prevent outbreaks. Existing methods for detection of gastrointestinal colonization of multidrug-resistant organisms (MDRO) are limited to specific organisms or resistance mechanisms. Metagenomic next-generation sequencing (mNGS) is a more rapid and agnostic diagnostic approach for microbiome and resistome investigations. We determined if mNGS can detect MDRO from rectal swabs in concordance with standard microbiology results. We performed and compared mNGS performance on short-read Illumina MiSeq (N = 10) and long-read Nanopore MinION (N = 5) platforms directly from rectal swabs to detect vancomycin-resistant enterococci (VRE) and carbapenem-resistant Gram-negative organisms (CRO). We detected Enterococcus faecium (N = 8) and Enterococcus faecalis (N = 2) with associated van genes (9/10) in concordance with VRE culture-based results. We studied the microbiome and identified CRO, Pseudomonas aeruginosa (N = 1), Enterobacter cloacae (N = 1), and KPC-producing Klebsiella pneumoniae (N = 1). Nanopore real-time analysis detected the blaKPC gene in 2.3 min and provided genetic context (blaKPC harbored on pKPC_Kp46 IncF plasmid). Illumina sequencing provided accurate allelic variant determination (i.e., blaKPC-2) and strain typing of the K. pneumoniae (ST-15). We demonstrated an agnostic approach for surveillance of MDRO, examining advantages of both short- and long-read mNGS methods for AMR detection.

Entities:  

Keywords:  Antimicrobial resistance; Metagenomics; Microbiome; Next-generation sequencing; Resistome; Surveillance

Mesh:

Substances:

Year:  2020        PMID: 32783106     DOI: 10.1007/s10096-020-03996-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  8 in total

1.  Evaluation of Multiple Methods for Detection of Gastrointestinal Colonization of Carbapenem-Resistant Organisms from Rectal Swabs.

Authors:  Patricia J Simner; Isabella Martin; Belita Opene; Pranita D Tamma; Karen C Carroll; Aaron M Milstone
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

2.  Outbreak of KPC-2-producing Enterobacteriaceae caused by clonal dissemination of Klebsiella pneumoniae ST307 carrying an IncX3-type plasmid harboring a truncated Tn4401a.

Authors:  Jung Ok Kim; Sae Am Song; Eun-Jeong Yoon; Jeong Hwan Shin; Hyukmin Lee; Seok Hoon Jeong; Kyungwon Lee
Journal:  Diagn Microbiol Infect Dis       Date:  2016-12-27       Impact factor: 2.803

3.  Identification of bacterial pathogens and antimicrobial resistance directly from clinical urines by nanopore-based metagenomic sequencing.

Authors:  K Schmidt; S Mwaigwisya; L C Crossman; M Doumith; D Munroe; C Pires; A M Khan; N Woodford; N J Saunders; J Wain; J O'Grady; D M Livermore
Journal:  J Antimicrob Chemother       Date:  2016-09-25       Impact factor: 5.790

4.  BLAST+: architecture and applications.

Authors:  Christiam Camacho; George Coulouris; Vahram Avagyan; Ning Ma; Jason Papadopoulos; Kevin Bealer; Thomas L Madden
Journal:  BMC Bioinformatics       Date:  2009-12-15       Impact factor: 3.169

5.  Rapid Nanopore Sequencing of Plasmids and Resistance Gene Detection in Clinical Isolates.

Authors:  Jamie K Lemon; Pavel P Khil; Karen M Frank; John P Dekker
Journal:  J Clin Microbiol       Date:  2017-10-11       Impact factor: 5.948

6.  metaSPAdes: a new versatile metagenomic assembler.

Authors:  Sergey Nurk; Dmitry Meleshko; Anton Korobeynikov; Pavel A Pevzner
Journal:  Genome Res       Date:  2017-03-15       Impact factor: 9.043

7.  Antimicrobial resistance prediction and phylogenetic analysis of Neisseria gonorrhoeae isolates using the Oxford Nanopore MinION sequencer.

Authors:  Daniel Golparian; Valentina Donà; Leonor Sánchez-Busó; Sunniva Foerster; Simon Harris; Andrea Endimiani; Nicola Low; Magnus Unemo
Journal:  Sci Rep       Date:  2018-12-04       Impact factor: 4.379

8.  Kraken: ultrafast metagenomic sequence classification using exact alignments.

Authors:  Derrick E Wood; Steven L Salzberg
Journal:  Genome Biol       Date:  2014-03-03       Impact factor: 13.583

  8 in total
  5 in total

1.  Performance Characteristics of Next-Generation Sequencing for the Detection of Antimicrobial Resistance Determinants in Escherichia coli Genomes and Metagenomes.

Authors:  Ashley M Rooney; Amogelang R Raphenya; Roberto G Melano; Christine Seah; Noelle R Yee; Derek R MacFadden; Andrew G McArthur; Pierre H H Schneeberger; Bryan Coburn
Journal:  mSystems       Date:  2022-06-01       Impact factor: 7.324

Review 2.  Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections.

Authors:  Zhenli Diao; Dongsheng Han; Rui Zhang; Jinming Li
Journal:  J Adv Res       Date:  2021-09-29       Impact factor: 12.822

3.  Profile of Bacteria with ARGs Among Real-World Samples from ICU Admission Patients with Pulmonary Infection Revealed by Metagenomic NGS.

Authors:  Huijuan Chen; Xinhua Bai; Yang Gao; Wenxuan Liu; Xuena Yao; Jing Wang
Journal:  Infect Drug Resist       Date:  2021-11-27       Impact factor: 4.003

4.  Application of Metagenomic Next-Generation Sequencing in Mycobacterium tuberculosis Infection.

Authors:  Yaoguang Li; Mengfan Jiao; Ying Liu; Zhigang Ren; Ang Li
Journal:  Front Med (Lausanne)       Date:  2022-04-01

5.  Evaluation of Metagenomic and Targeted Next-Generation Sequencing Workflows for Detection of Respiratory Pathogens from Bronchoalveolar Lavage Fluid Specimens.

Authors:  David C Gaston; Heather B Miller; John A Fissel; Emily Jacobs; Ethan Gough; Jiajun Wu; Eili Y Klein; Karen C Carroll; Patricia J Simner
Journal:  J Clin Microbiol       Date:  2022-06-13       Impact factor: 11.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.